Quoin Pharmaceuticals, Ltd. (QNRX) Reports Q2 Loss of $3.24/sh
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q2 EPS of ($3.24), versus ($18.05) reported last year.
For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.
